Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
60.6M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
3.83M
-
Shares change
-
-669K
-
Total reported value, excl. options
-
$12.9M
-
Value change
-
-$685K
-
Number of buys
-
19
-
Number of sells
-
-13
-
Price
-
$3.37
Significant Holders of Immuneering Corp - Class A Common Stock (IMRX) as of Q2 2025
46 filings reported holding IMRX - Immuneering Corp - Class A Common Stock as of Q2 2025.
Immuneering Corp - Class A Common Stock (IMRX) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.83M shares
of 60.6M outstanding shares and own 6.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.06M shares), MARSHALL WACE, LLP (574K shares), BlackRock, Inc. (423K shares), SOUTHPORT MANAGEMENT, L.L.C. (245K shares), GEODE CAPITAL MANAGEMENT, LLC (230K shares), FMR LLC (221K shares), MORGAN STANLEY (201K shares), HighTower Advisors, LLC (136K shares), STATE STREET CORP (97.3K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (95.4K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.